Literature DB >> 196944

Modulation of smooth muscle activity by catecholamines.

J M Marshall.   

Abstract

The inhibitory and excitatory actions of catecholamines are compared in various types of smooth muscle. Inhibition is usually but not invariably associated with membrane hyperpolarization and a decrease in membrane resistance. It also has a metabolic component frequently involving an increase in tissue cAMP. In some cases, the metabolic component is related to a cation pump, but the nature of this pump is unclear. With the exception of intestinal muscle where inhibition results from the synergistic action of alpha and beta receptors, inhibition is caused by activation of beta receptors. Excitation is mediated by alpha activation and is usually accompanied by a decrease in membrane potential and membrane resistance. Only the uterus has a metabolic component. The specific ionic permeability changes accompanying excitation are different in various smooth muscles. Clarification of the mechanisms responsible for these differential actions in various types of smooth muscle is a challenge for future work.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196944

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  6 in total

1.  Dual regulation of M current in gastric smooth muscle cells: beta-adrenergic-muscarinic antagonism.

Authors:  S M Sims; L H Clapp; J V Walsh; J J Singer
Journal:  Pflugers Arch       Date:  1990-11       Impact factor: 3.657

2.  Effects of beta-adrenergic stimulation on calcium movements in rabbit aortic smooth muscle: relationship with cyclic AMP.

Authors:  K D Meisheri; C van Breemen
Journal:  J Physiol       Date:  1982-10       Impact factor: 5.182

3.  The action of isoprenaline on the smooth muscle of the guinea-pig taenia coli.

Authors:  E Bülbring; A den Hertog
Journal:  J Physiol       Date:  1980-07       Impact factor: 5.182

4.  Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.

Authors:  T B Bolton; R J Lang; B Ottesen
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

5.  Cellular localization of the inhibitory action of relaxin against uterine spasm.

Authors:  S J Hughes; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  The lack of a role for potassium channel opening in the action of relaxin in the rat isolated uterus; a comparison with levcromakalim and salbutamol.

Authors:  S J Hughes; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.